Make a donation Start a fundraiser
  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us
  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us
Bowel Cancer

Bowel Cancer

Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer

[…]

Read More… from Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer

Effects of High and Low EphB4 Receptor Expression on Colorectal Cancer Cell Behaviour and Tumour Growth, Vascularisation and Composition

[…]

Read More… from Effects of High and Low EphB4 Receptor Expression on Colorectal Cancer Cell Behaviour and Tumour Growth, Vascularisation and Composition

Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines

[…]

Read More… from Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines

Krill oil extract inhibits the migration of human colorectal cancer cells and down-regulates EGFR signalling and PD-L1 expression

[…]

Read More… from Krill oil extract inhibits the migration of human colorectal cancer cells and down-regulates EGFR signalling and PD-L1 expression

Krill oil extract suppresses the proliferation of colorectal cancer cells through activation of caspase 3/9

[…]

Read More… from Krill oil extract suppresses the proliferation of colorectal cancer cells through activation of caspase 3/9

Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth

[…]

Read More… from Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth

Effects of EphB4 receptor expression on colorectal cancer cells, tumor growth, vascularization and composition

[…]

Read More… from Effects of EphB4 receptor expression on colorectal cancer cells, tumor growth, vascularization and composition

Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis in vitro and in vivo

[…]

Read More… from Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis in vitro and in vivo

Carfilzomib Promotes the Unfolded Protein Response and Apoptosis in Cetuximab-Resistant Colorectal Cancer

[…]

Read More… from Carfilzomib Promotes the Unfolded Protein Response and Apoptosis in Cetuximab-Resistant Colorectal Cancer

Down regulation of urokinase plasminogen activator expression inhibits Erk signaling with concomitant suppression of matrix metalloprotease-9 (MMP-9) due to loss of uPAR-b1 integrin complex in colon cancer.

[…]

Read More… from Down regulation of urokinase plasminogen activator expression inhibits Erk signaling with concomitant suppression of matrix metalloprotease-9 (MMP-9) due to loss of uPAR-b1 integrin complex in colon cancer.

The comparative anti-cancer effects of krill oil and oxaliplatin in an orthotopic mouse model of colorectal cancer

[…]

Read More… from The comparative anti-cancer effects of krill oil and oxaliplatin in an orthotopic mouse model of colorectal cancer

Krill oil supplementation reduces the growth of CT-26 orthotopic tumours in Balb/c mice. Jayathilake AG, Kadife E, Kuol N, Luwor RB, Nurgali K, Su XQ

[…]

Read More… from Krill oil supplementation reduces the growth of CT-26 orthotopic tumours in Balb/c mice. Jayathilake AG, Kadife E, Kuol N, Luwor RB, Nurgali K, Su XQ

Molecular Mechanisms Associated with the Inhibitory Role of Long Chain n-3 PUFA in Colorectal Cancer

[…]

Read More… from Molecular Mechanisms Associated with the Inhibitory Role of Long Chain n-3 PUFA in Colorectal Cancer

A Role for MAIT Cells in Colorectal Cancer

[…]

Read More… from A Role for MAIT Cells in Colorectal Cancer

Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.

[…]

Read More… from Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.

Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the b6 integrin subunit.

[…]

Read More… from Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the b6 integrin subunit.

Proteomic profiling of proteins associated with urokinase plasminogen activator receptor (uPAR) in colon cancer cells using an antisense approach

[…]

Read More… from Proteomic profiling of proteins associated with urokinase plasminogen activator receptor (uPAR) in colon cancer cells using an antisense approach

  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us

Fundraisers

News & media

  • Irene’s memory to make a difference to research.
  • Creswick Community Bank
  • Skin cell breakthrough could lead to new treatments.
  • New finding from Breast cancer group.

Contact

admin@fecri.org.au



Phone

03 5331 3101

Location

Ballarat Technology Park
- Central Suite 23,
106-110 Lydiard St Sth
Ballarat Vic 3350

Postal

PO Box 549,
Ballarat VIC 3350

All material © Fiona Elsey Cancer Research Institute.

Site by
Pepper Brandmanagers